Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia
Authors:
- О. П. РотарьОРО. П. Ротарь
- A. M. ErinaAEA. M. Erina
- E. V. MoguchaiaEME. V. Moguchaia
- E. P. KolesovaEKE. P. Kolesova
- K. M. TolkunovaKTK. M. Tolkunova
- A. R. GorshevayaAGA. R. Gorshevaya
- E. A. SmirnovaESE. A. Smirnova
- Ya. A. BelenikinaYBYa. A. Belenikina
- I. V. BikushovaIBI. V. Bikushova
- M. A. KerchevaMKM. A. Kercheva
Open Access
- 15 April 2022
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (4) , 5014
Abstract
Repetitive quarantines and social restrictions during the coronavirus disease 2019 (COVID-19) pandemic have negatively affected the population health in general, and the control of hypertension (HTN) in particular.Aim. To evaluate the control of HTN in the Russian population during the COVID-19 period based on the results of screening for HTN May Measurement Month 2021 (MMM2021).Material and methods. During May-August 2021, 2491 participants from 11 Russian regions took part in the screening. Participation was voluntary without restrictions on sex. All participants were over 18 years of age. During the screening, blood pressure (BP) was measured three times using automatic and mechanical BP monitors. In addition, a questionnaire was filled out on behavioral risk factors, comorbidities and therapy. HTN was diagnosed with systolic BP ≥140 mmHg and/ or diastolic blood pressure ≥90 mmHg and/or taking antihypertensive therapy. The questionnaire included questions about prior COVID-19, vaccinations and their impact on the intake of antihypertensive drugs.Results. The analysis included data from 2461 respondents aged 18 to 92, of which 963 were men (39,1%). The proportion of hypertensive patients was 41,0%, while among them 59,0% took antihypertensives and 30,9% were effectively treated. In comparison with pre-pandemic period according to MMM2018-2019, the higher proportion of HTN patients in the Russian sample was revealed during MMM2021 (41,0% vs 31,3%, pConclusion. According to HTN screening in Russia, there is persistent ineffective control of HTN, which may be due to both the worsening pattern of behavioral risk factors, limited access to healthcare during COVID-19, and the inertia of physicians and low adherence of patients due to the asymptomatic HTN course in the majority.Keywords
This publication has 17 references indexed in Scilit:
- Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemicJournal Of Hypertension, 2020
- Hypertension and dietary patterns of the adult population. Results of the Russian epidemiological study ESSE-RFCardiovascular Therapy and Prevention, 2020
- May Measurement Month 2019Hypertension, 2020
- Drinking alone: COVID-19, lockdown, and alcohol-related harmThe Lancet Gastroenterology & Hepatology, 2020
- May Measurement Month 2019: adherence to treatment and hypertension control in RussiaRussian Journal of Cardiology, 2020
- Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)Rational Pharmacotherapy in Cardiology, 2019
- Corrigendum to: May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of HypertensionEuropean Heart Journal, 2019
- May Measurement Month 2017 in Russia: hypertension treatment and control—EuropeEuropean Heart Journal Supplements, 2019
- May Measurement Month 2017: an analysis of blood pressure screening results worldwideThe Lancet Global Health, 2018
- ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCDCardiovascular Therapy and Prevention, 2014